Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope
Yong Lu(China Pharmaceutical University), Jingjing Liu(Tianjin Medical University Cancer Institute and Hospital), Huiyong Zhang(Henan Medical University), Xiangbing Hu(China Pharmaceutical University), Yu Zhang(Wannan Medical College), Rongyue Cao(China Pharmaceutical University), Yanjun Ma(China Pharmaceutical University), Guojun Wu(China Pharmaceutical University), Kedong Ouyang(China Pharmaceutical University), Taiming Li(China Pharmaceutical University), Jing Fang(Fujian Institute of Oceanography), Hao Fan
Cited by 29
Related Papers
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
|Cancer Letters|2008|216
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆
|Annals of Oncology|2021|212